These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19248391)

  • 1. Editors' introduction: California Substance Abuse Research Consortium, 2007: a focus on women.
    Rutkowski B; Freese T; Rawson R
    J Psychoactive Drugs; 2008 Nov; Suppl 5():321-3. PubMed ID: 19248391
    [No Abstract]   [Full Text] [Related]  

  • 2. Editors' introduction: The evidence for integrated care-substance use disorders, mental health and primary care: California Substance Abuse Research Consortium (SARC) meetings, 2011.
    Rutkowski BA; Rawson RA; Freese TE
    J Psychoactive Drugs; 2012; 44(4):281-4. PubMed ID: 23210375
    [No Abstract]   [Full Text] [Related]  

  • 3. Editors' introduction: Identifying and assessing promising practices for criminal justice clients--California Substance Abuse Research Consortium (SARC) meetings, 2010.
    Urada D; Rutkowski BA; Rawson RA; Freese TE
    J Psychoactive Drugs; 2011 Sep; Suppl 7():3-9. PubMed ID: 22185034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance Abuse Research Consortium (SARC) introduction: moving forward to improve addiction treatment in California.
    Zito R
    J Psychoactive Drugs; 2010 Sep; Suppl 6():205-6. PubMed ID: 21138195
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving the addiction treatment system in California through the use of data and evidence-based practices--California Substance Abuse Research Consortium (SARC) meetings, 2009 [editorial].
    Rutkowski BA; Rawson RA; Freese TE
    J Psychoactive Drugs; 2010 Sep; Suppl 6():207-10. PubMed ID: 21138196
    [No Abstract]   [Full Text] [Related]  

  • 6. Substance abuse and schizophrenia: editors' introduction.
    Kosten TR; Ziedonis DM
    Schizophr Bull; 1997; 23(2):181-6. PubMed ID: 9165628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editors' Commentary for Special Issue: The 2017 CALDAR Summer Institute and International Conference Promoting Global Health-Precision Research in Substance Abuse, HIV, and Care.
    Chang L; Li MD; Hser YI
    J Neuroimmune Pharmacol; 2018 Dec; 13(4):427-429. PubMed ID: 30382511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse comorbidity in schizophrenia: editors' introduction.
    Lieberman JA; Bowers MB
    Schizophr Bull; 1990; 16(1):29-30. PubMed ID: 2333479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to "Substance abuse and schizophrenia: editors' introduction".
    van Ammers EC
    Schizophr Bull; 1998; 24(2):183. PubMed ID: 9613618
    [No Abstract]   [Full Text] [Related]  

  • 10. CCCSAPR: a new approach to drug policy research in the twenty-first century. California Collaborative Center for Substance Abuse Policy Research.
    Smith DE; Seymour RB
    J Psychoactive Drugs; 2000; 32(4):359-61. PubMed ID: 11210196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. California Substance Abuse Research Consortium, May 2003: update on recent substance abuse trends.
    Finnerty BA
    J Psychoactive Drugs; 2004 May; Suppl 2():103-8. PubMed ID: 15279121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editors' introduction: policy change and policy analysis.
    Bergeron H; Reuter P
    Int J Drug Policy; 2009 Nov; 20(6):455-7. PubMed ID: 19560333
    [No Abstract]   [Full Text] [Related]  

  • 13. Substance ABUSE Research Consortium (SARC): introduction.
    Jett KP
    J Psychoactive Drugs; 2007 Nov; Suppl 4():313-7. PubMed ID: 18284097
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring and reporting alcohol and drug use trends in California: the California Substance Abuse Research Consortium meetings.
    Finnerty BA
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():119-25. PubMed ID: 12825754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The California Substance Abuse Research Consortium: origins, history, and issues.
    Anglin MD; Urada D
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():109-17. PubMed ID: 12825753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editors' introduction: evolving insights into the drug--crime nexus.
    Harrison LD; Backenheimer M
    Subst Use Misuse; 1998 Jul; 33(9):1763-77. PubMed ID: 9718179
    [No Abstract]   [Full Text] [Related]  

  • 17. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editors' Introduction to this Special Issue on Club Drug Epidemiology.
    Fendrich M; Johnson TP
    Subst Use Misuse; 2005; 40(9-10):1179-84. PubMed ID: 16048811
    [No Abstract]   [Full Text] [Related]  

  • 19. Substance abuse and criminal recidivism: a prospective study of adolescents.
    Wilson JJ; Rojas N; Haapanen R; Duxbury E; Steiner H
    Child Psychiatry Hum Dev; 2001; 31(4):297-312. PubMed ID: 11227989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From generic to gender-responsive treatment: changes in social policies, treatment services, and outcomes of women in substance abuse treatment.
    Grella CE
    J Psychoactive Drugs; 2008 Nov; Suppl 5():327-43. PubMed ID: 19256044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.